HIV i-Base news story
A new modelling study, published as an open-access paper in Nature Communications, provides further evidence that the efficacy of oral PrEP is driven by drug levels in immune cells (PBMCs), rather than levels in blood, genital or rectal tissue.
These results directly affect the practical advice about adherence and how often different people need to take PrEP, supporting recent UK guidelines.
Read the full news story here.
Source : HIV i-Base
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.